Epstein-Barr virus-associated gastric carcinoma.

[1]  Y. Seto,et al.  Gastric carcinoma with osteoclast‐like giant cells. Lymphoepithelioma‐like carcinoma with Epstein–Barr virus infection is the predominant type , 2010, Pathology international.

[2]  M. Fukayama.  Epstein‐Barr virus and gastric carcinoma , 2010, Pathology international.

[3]  R. Pfeiffer,et al.  Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. , 2009, Gastroenterology.

[4]  K. Ohtomo,et al.  CT appearance of Epstein-Barr virus-associated gastric carcinoma , 2009, Abdominal Imaging.

[5]  M. Fukayama,et al.  Epstein-Barr Virus-associated Gastric Carcinoma: A Distinct Carcinoma of Gastric Phenotype by Claudin Expression Profiling , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  J. Minárovits,et al.  Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. , 2009, Seminars in cancer biology.

[7]  S. Ishikawa,et al.  Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. , 2009, Cancer research.

[8]  Ju-Han Lee,et al.  Clinicopathological and molecular characteristics of Epstein–Barr virus‐associated gastric carcinoma: A meta‐analysis , 2009, Journal of gastroenterology and hepatology.

[9]  M. Pomper,et al.  Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors , 2008, Nature Medicine.

[10]  M. Fukayama,et al.  Epstein–Barr virus and gastric carcinoma: virus–host interactions leading to carcinoma , 2008, Cancer science.

[11]  J. Karras,et al.  STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. , 2008, Journal of Clinical Investigation.

[12]  M. Esteller.  Epigenetics in cancer. , 2008, The New England journal of medicine.

[13]  M. Fukayama,et al.  Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. , 2008, Cancer research.

[14]  S. Akiba,et al.  Epstein‐Barr virus associated gastric carcinoma: Epidemiological and clinicopathological features , 2008, Cancer science.

[15]  T. Tsukamoto,et al.  Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non‐cancerous gastric mucosae , 2007, Cancer science.

[16]  Y. M. Lee,et al.  Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. , 2007, Cancer letters.

[17]  M. Fukayama,et al.  Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma , 2006, Journal of Gastroenterology.

[18]  H. Fujii,et al.  CpG Island M`ethylation Status in Gastric Carcinoma with and without Infection of Epstein-Barr Virus , 2006, Clinical Cancer Research.

[19]  S. Akiba,et al.  Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population. , 2005, World journal of gastroenterology.

[20]  M. Fukayama,et al.  Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma , 2005, Journal of Gastroenterology.

[21]  M. Fukayama,et al.  High‐density methylation of p14ARF and p16INK4A in Epstein‐Barr virus–associated gastric carcinoma , 2004, International journal of cancer.

[22]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[23]  I. Flinn,et al.  Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  K. Yanagihara,et al.  Characterization of Epstein-Barr virus infection in a human signet ring cell gastric carcinoma cell line, HSC-39. , 2004, Microbes and infection.

[25]  M. Fukayama,et al.  Promoter hypermethylation of E‐cadherin and its abnormal expression in Epstein‐Barr virus‐associated gastric carcinoma , 2004, International journal of cancer.

[26]  Dong-jik Shin,et al.  A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. , 2004, Virology.

[27]  C. V. D. van de Velde,et al.  EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  K. Takada,et al.  Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. , 2003, Cancer research.

[29]  V. Pankratz,et al.  Lymphocyte-Rich Gastric Cancer: Associations with Epstein-Barr Virus, Microsatellite Instability, Histology, and Survival , 2003, Modern Pathology.

[30]  H. Lee,et al.  Epstein–Barr virus and microsatellite instability in gastric carcinogenesis , 2003, The Journal of pathology.

[31]  H. Aburatani,et al.  Global and non‐random CpG‐island methylation in gastric carcinoma associated with Epstein‐Barr virus , 2003, Cancer science.

[32]  A. Kaneda,et al.  Identification of silencing of nine genes in human gastric cancers. , 2002, Cancer research.

[33]  M. Gulley,et al.  Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors , 2002, Journal of Virology.

[34]  M. Fukayama,et al.  Reduced Expression and Promoter Methylation p16 Gene in Epstein‐Barr Virus‐associated Gastric Carcinoma , 2002, Japanese journal of cancer research : Gann.

[35]  G. Offerhaus,et al.  Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. , 2002, The American journal of pathology.

[36]  M. Gulley,et al.  Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation , 2002, Journal of clinical pathology.

[37]  W. Kim,et al.  Epstein-Barr virus, p53 protein, and microsatellite instability in the adenoma-carcinoma sequence of the stomach. , 2002, Human pathology.

[38]  S. Kenney,et al.  Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. , 2002, Cancer research.

[39]  C. Woodman,et al.  Low prevalence of Epstein–Barr virus in incident gastric adenocarcinomas from the United Kingdom , 2002, British Journal of Cancer.

[40]  M. Rhyu,et al.  Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. , 2002, The American journal of pathology.

[41]  K. Okita,et al.  GI Cancer High Prevalence of Epstein-Barr Virus in Gastric Remnant Carcinoma after Billroth-II Reconstruction , 2002, Scandinavian journal of gastroenterology.

[42]  S. Akiba,et al.  Epstein‐Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: A study in one area of Chile , 2001, International journal of cancer.

[43]  E. Kuipers,et al.  Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. , 2001, Gastroenterology.

[44]  S. Natsugoe,et al.  Epstein‐Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms , 2001, Journal of medical virology.

[45]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[46]  J. Peiris,et al.  Epstein-Barr virus (EBV) infection in infancy. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[47]  H. Mitomi,et al.  Possible association of active gastritis, featuring accelerated cell turnover and p53 overexpression, with cancer development at anastomoses after gastrojejunostomy. Comparison with gastroduodenostomy. , 2000, American journal of clinical pathology.

[48]  H. Lee,et al.  Microsatellite instability and Epstein–Barr virus infection in gastric remnant cancers , 2000, Pathology international.

[49]  H. P. Wang,et al.  Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. , 2000, Gastroenterology.

[50]  Jaap M Middeldorp,et al.  Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. , 2000, Cancer research.

[51]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[52]  G. Lenz,et al.  Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. , 1999, Blood.

[53]  M. Fukayama,et al.  Atrophic gastritis, Epstein–Barr virus infection, and Epstein–Barr virus-associated gastric carcinoma , 1999, Gastric Cancer.

[54]  Q. Tao,et al.  Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. , 1999, The American journal of pathology.

[55]  S. Nakamura,et al.  Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma. , 1999, The Journal of clinical investigation.

[56]  K. Takada,et al.  Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt’s Lymphoma Cell Line Akata , 1998, Journal of Virology.

[57]  T. Ragoczy,et al.  The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes , 1998, Journal of Virology.

[58]  M. Fukayama,et al.  Establishment and Characterization of a Human Epstein-Barr Virus-Associated Gastric Carcinoma in SCID Mice , 1998, Journal of Virology.

[59]  I. Baas,et al.  Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. , 1998, Journal of clinical pathology.

[60]  T. Katsumoto,et al.  Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues. , 1998, Virology.

[61]  K. Takada,et al.  Cell-to-Cell Contact as an Efficient Mode of Epstein-Barr Virus Infection of Diverse Human Epithelial Cells , 1998, Journal of Virology.

[62]  C. Land,et al.  Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. , 1998, Cancer Epidemiology, Biomarkers and Prevention.

[63]  K. Okinaga,et al.  Establishment of Epstein‐Barr Virus‐positive Human Gastric Epithelial Cell Lines , 1998, Japanese journal of cancer research : Gann.

[64]  M. Kobayashi,et al.  Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[65]  T. Osato.  EPSTEIN-BARR VIRUS INFECTION AND ONCOGENESIS , 1998 .

[66]  C. Land,et al.  Epstein‐Barr‐virus‐associated gastric cancer in Russia , 1997, International Journal of Cancer.

[67]  M. Koike,et al.  Drastic genetic instability of tumors and normal tissues in Turcot syndrome , 1997, Oncogene.

[68]  M. Fukayama,et al.  Microsatellite instability and loss of heterozygosity in gastric lymphoma. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[69]  K. Robertson,et al.  Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter , 1997, Journal of virology.

[70]  M. Fukayama,et al.  Expression of CD44 variants in gastric carcinoma with or without Epstein‐Barr virus , 1997, International journal of cancer.

[71]  H. Yoshiyama,et al.  Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21 , 1997, Journal of virology.

[72]  D. Thorley-Lawson,et al.  Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell , 1997 .

[73]  M. Stolte,et al.  Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists , 1997, The Lancet.

[74]  C. Land,et al.  Morphological characteristics of Epstein‐Barr virus‐related early gastric carcinoma: A case‐control study , 1997, Pathology international.

[75]  Y. Tomita,et al.  Epstein‐Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: Association with clinico‐pathologic factors and HLA‐subtype , 1997 .

[76]  D. Moss,et al.  Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. , 1997, Annual review of immunology.

[77]  T. Osato,et al.  Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. , 1996, British Journal of Cancer.

[78]  H. Ohtani,et al.  Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[79]  K. Hayashi,et al.  In situ detection of Epstein-Barr virus in the gastric glands with intestinal metaplasia. , 1996, American Journal of Gastroenterology.

[80]  F. Konishi,et al.  Characteristics of Epstein‐Barr virus‐associated gastric carcinoma with lymphoid stroma in Japan , 1996, Cancer.

[81]  T. Ooka,et al.  Transcriptional expression of Epstein‐Barr virus genes and proto‐oncogenes in North African nasopharyngeal carcinoma , 1996 .

[82]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[83]  G. Tamura,et al.  Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. , 1995, Cancer research.

[84]  W. Chen,et al.  Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[85]  G. Ott,et al.  Monoclonal Epstein‐Barr virus genomes but lack of EBV‐related protein expression in different types of gastric carcinoma , 1994, Histopathology.

[86]  T. Osato,et al.  Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[87]  K. Takada,et al.  Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV , 1994, Journal of virology.

[88]  M. Fukayama,et al.  Microsatellite instability in the progression of gastric carcinoma. , 1994, Cancer research.

[89]  C. Land,et al.  Epstein‐Barr virus and gastric remnant cancer , 1994, Cancer.

[90]  M. Fukayama,et al.  Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[91]  M. Tsuneyoshi,et al.  Epstein‐Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis , 1994 .

[92]  M. Fukayama,et al.  Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential , 1994, Cancer.

[93]  C. Land,et al.  Epstein-Barr virus in gastric carcinoma. , 1993, The American journal of pathology.

[94]  M. Fukayama,et al.  Epstein-Barr virus in pyothorax-associated pleural lymphoma. , 1993, The American journal of pathology.

[95]  A. Mikata,et al.  Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. , 1993, The American journal of pathology.

[96]  M. Tiemann,et al.  Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. , 1993, Blood.

[97]  J. Laissue,et al.  Distribution and localization of Epstein–Barr virus subtypes A and B in AIDS‐related lymphomas and lymphatic tissue of HIV‐positive patients , 1992, The Journal of pathology.

[98]  D. Shibata,et al.  Epstein-Barr virus-associated gastric adenocarcinoma. , 1992, The American journal of pathology.

[99]  D. Shibata,et al.  Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. , 1991, The American journal of pathology.

[100]  K. Min,et al.  Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas) of the stomach. Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction. , 1991, American journal of clinical pathology.

[101]  H. Ito,et al.  Gastric carcinoma with lymphoid stroma: pathological and immunohistochemical analysis. , 1990, Hiroshima journal of medical sciences.

[102]  L. Sobin,et al.  Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[103]  I. Ernberg,et al.  The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. , 1989, The Journal of general virology.

[104]  T. Tursz,et al.  Epstein-Barr virus gene expression in nasopharyngeal carcinoma. , 1988, The Journal of general virology.

[105]  R. Warnke,et al.  Epstein-Barr viral DNA in tissues of Hodgkin's disease. , 1987, The American journal of pathology.

[106]  L. Young,et al.  Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.

[107]  G. Nemerow,et al.  Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d , 1987, Journal of virology.

[108]  P. L. Deininger,et al.  DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.

[109]  P. A. Biro,et al.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[110]  N. Raab-Traub,et al.  Epstein-Barr virus replication in oropharyngeal epithelial cells. , 1984, The New England journal of medicine.

[111]  I. M. Shapiro,et al.  Infection of normal human epithelial cells by Epstein-Barr virus. , 1983, Science.

[112]  H. Watanabe,et al.  Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations , 1976, Cancer.

[113]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[114]  J. Davies.  CASE IN WHICH A FŒTUS WAS PASSED BY THE ANUS. , 1831 .

[115]  M. Fukayama,et al.  Prominent Mott cell proliferation in Epstein-Barr virus-associated gastric carcinoma. , 2010, Human pathology.

[116]  M. Fukayama,et al.  Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms. , 2008, International journal of clinical and experimental pathology.

[117]  M. Fukayama,et al.  p73 gene promoter methylation in Epstein‐Barr virus‐associated gastric carcinoma , 2007, International journal of cancer.

[118]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[119]  T. Hattori,et al.  Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach , 2005, Journal of Cancer Research and Clinical Oncology.

[120]  E. Tahara.  Molecular mechanism of stomach carcinogenesis , 2005, Journal of Cancer Research and Clinical Oncology.

[121]  J. Minárovits,et al.  Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. , 2003, Advances in cancer research.

[122]  H. Aburatani,et al.  Interleukin-1 (cid:2) Expression in Human Gastric Carcinoma with Epstein-Barr Virus Infection , 2002 .

[123]  W. H. Kim,et al.  Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. , 2001, Pathology, research and practice.

[124]  喜島 祐子.  Among various epithelial neoplasms,Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma , 2001 .

[125]  H. Herbst,et al.  Epstein-Barr virus infection and the pathogenesis of malignant lymphomas. , 1997, Cancer surveys.

[126]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[127]  N. Raab-Traub.  Epstein-Barr virus and nasopharyngeal carcinoma. , 1992, Seminars in cancer biology.

[128]  Evans As.  Clinical syndromes associated with EB virus infection. , 1972 .